Pharmaceutical Articles

Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.

Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.

Adverse events tied to steroid shots made by Tenn. compounding pharmacy
Posted: May 25, 2013

Seven cases of adverse events, including at least one involving a fungus, connected to steroid injections manufactured by a Tennessee compounding pharmacy have been reported to the Food and Drug Administration (FDA) and the Tennessee Board of Pharmacy. The FDA

One-third of women who undergo transvaginal mesh surgeries have complications
Posted: May 25, 2013

A third of patients who undergo surgery to repair common pelvic floor disorders experience complications, according to a new study published in the Journal of the American Medical Association.

Cause of Alabama mystery illness revealed
Posted: May 24, 2013

The mystery has been solved. The illness that sickened 10, sending seven to the hospital and killing two in southeast Alabama has been identified as a combination of type A flu, rhinovirus, and bacterial pneumonia, the Alabama Department of Public

AAJ asks FDA not to protect artificial hip makers from liability claims
Posted: May 24, 2013

The American Association for Justice (AAJ), a plaintiff lawyers industry group, is asking the Food and Drug Administration (FDA) to prevent makers of metal-on-metal hip implants from using a proposed change in the medical device approval process to protect them

Three more hospitalized in Alabama with mystery illness
Posted: May 23, 2013

Three more people from southeast Alabama have fallen ill from a mystery disease since state health officials alerted the media Wednesday that an investigation into the cause of the illness was underway. To date, 10 people have been hospitalized, two

Abbott recalls all FreeStyle InsuLinx Blood Glucose Meters
Posted: May 23, 2013

Abbott Diabetes Care is recalling its FreeStyle InsuLinx Blood Glucose Meters because if the blood sugar level is 1024 mg/dL or above the device will display and store in memory an incorrect test result that is far below that level, which

Illnesses prompt another recall of compounding pharmacy products due to sterility concerns
Posted: May 23, 2013

All sterile products made and distributed by a Dallas-based compounding pharmacy are being recalled after an inspection of the facility uncovered poor sterile production practices. The inspection occurred after the Food and Drug Administration (FDA) received reports of fever, flu-like

Mystery illness hospitalizes 7, kills 2 in southeast Alabama
Posted: May 22, 2013

Two people have died and at least seven have been hospitalized by a mystery illness in Alabama. All seven cases were reported at one hospital in Dothan and come from a 10-county area in the southeast corner of the state.

For-profit dialysis clinics use more costly and dangerous drugs
Posted: May 21, 2013

For-profit dialysis kidney centers use more of an expensive and dangerous class of drugs than nonprofit clinics, according to a report published this week in JAMA Internal Medicine. The drugs are known as erythropoiesis-stimulation agents (ESAs) such as Amgen’s Epogen.

Victims of fungal meningitis outbreak deserve compensation for their pain and suffering
Posted: May 21, 2013

The days when Brian Kennedy can rate his pain as an 8 out of 10 are “good days,” but most often it feels more like a 9 or 10 even with the potent painkiller oxycodone in his system. Kennedy is